BioAge Labs Inc. (BIOA)
NASDAQ: BIOA
· Real-Time Price · USD
5.69
0.18 (3.27%)
At close: Oct 15, 2025, 3:59 PM
5.69
0.00%
After-hours: Oct 15, 2025, 06:01 PM EDT
3.27% (1D)
| Bid | 5.66 |
| Market Cap | 203.99M |
| Revenue (ttm) | 3.86M |
| Net Income (ttm) | -79.03M |
| EPS (ttm) | -6.81 |
| PE Ratio (ttm) | -0.84 |
| Forward PE | -2.19 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 5.72 |
| Volume | 112,168 |
| Avg. Volume (20D) | 153,914 |
| Open | 5.53 |
| Previous Close | 5.51 |
| Day's Range | 5.53 - 5.73 |
| 52-Week Range | 2.88 - 26.62 |
| Beta | 1.81 |
| Ex-Dividend Date | n/a |
About BIOA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BIOA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BIOA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBioAge Labs Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
10 months ago
+4.88%
BioAge Labs shares are trading higher after the co...
Unlock content with
Pro Subscription
10 months ago
-76.85%
BioAdge Labs shares are trading lower after Jefferies downgraded the stock from Buy to Hold and Citigroup downgraded the stock from Buy to Neutral. Additionally, both firms cut their price target on the stock to $7.
2 months ago · fool.com
BioAge Labs (BIOA) Q2 Revenue Hits $2.4MBioAge Labs (BIOA) Q2 Revenue Hits $2.4M